A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with numerous of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in users administering substances of uncertain source.
Some experts stated the demand for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.
Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.
Platform Response and Content Removal
Based on TikTok, the platform has removed violative material and banned related keywords and search suggestions. The company stated it was committed to maintaining the service safe and investing in enhancing enforcement strategies.
Online Trading Operations
Research also found communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with photos of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.
Within minutes of joining one group, a seller posted WhatsApp details, where most transactions occur. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.
Product Information and Costs
Within these groups, posts display dark colored parcels with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.
Her team has previously seen patients harmed by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly serious health risks”.
